• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[uroplakin III,一种尿路上皮伞细胞的特异性膜蛋白,作为转移性移行细胞癌的组织学标志物]

[Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].

作者信息

Moll R, Laufer J, Wu X R, Sun T T

机构信息

Institut für Pathologie der Universität Mainz.

出版信息

Verh Dtsch Ges Pathol. 1993;77:260-5.

PMID:7511294
Abstract

We have investigated, by immunohistochemical staining of various paraffin-embedded carcinoma sections, the tissue-specific expression of uroplakin III--a recently characterized constituent glycoprotein (47 kD) of the asymmetrical unit membrane which forms plaques on apical surface of urothelial umbrella cells. The apical membrane pattern of normal urothelial umbrella cells was in part maintained in papillary transitional cell carcinomas (TCCs). In addition, in both papillary and invasive TCCs, variously sized lumina exhibited positive membrane staining of uroplakin III. In some cases, basal cell membrane staining was seen. Positive reactions (which sometimes were very focal) were noted in 16/18 papillary non-invasive TCCs (89%), 21/37 invasive TCCs (57%) and 12/15 TCC metastases (80%). Non-TCC carcinomas of different origin (n = 63) were consistently negative. These results show that uroplakin III may serve as a useful marker for TCCs, revealing specific urothelial differentiation features to be expressed in such tumors even after metastasis. This marker, while of only intermediate sensitivity, is highly specific, thus opening interesting histodiagnostic possibilities in the case of unclear carcinoma metastases.

摘要

我们通过对各种石蜡包埋的癌组织切片进行免疫组织化学染色,研究了尿路上皮蛋白III的组织特异性表达。尿路上皮蛋白III是一种最近鉴定出的不对称单位膜组成糖蛋白(47kD),在尿路上皮伞细胞的顶端表面形成斑块。正常尿路上皮伞细胞的顶端膜模式在乳头状移行细胞癌(TCC)中部分得以保留。此外,在乳头状和浸润性TCC中,大小各异的管腔均显示尿路上皮蛋白III的膜阳性染色。在某些病例中,可见基底细胞膜染色。在16/18例乳头状非浸润性TCC(89%)、21/37例浸润性TCC(57%)和12/15例TCC转移灶(80%)中观察到阳性反应(有时非常局限)。不同起源的非TCC癌(n = 63)始终为阴性。这些结果表明,尿路上皮蛋白III可能作为TCC的有用标志物,揭示即使在转移后此类肿瘤中仍表达的特定尿路上皮分化特征。该标志物虽然敏感性仅为中等,但具有高度特异性,因此在癌转移情况不明时开辟了有趣的组织诊断可能性。

相似文献

1
[Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].[uroplakin III,一种尿路上皮伞细胞的特异性膜蛋白,作为转移性移行细胞癌的组织学标志物]
Verh Dtsch Ges Pathol. 1993;77:260-5.
2
Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.尿路上皮斑块蛋白,即尿路上皮伞细胞的特异性膜蛋白,作为转移性移行细胞癌的组织学标志物。
Am J Pathol. 1995 Nov;147(5):1383-97.
3
Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.uroplakin III是原发性和转移性尿路上皮癌的一种高度特异性且中度敏感的免疫组化标志物。
Am J Clin Pathol. 2000 May;113(5):683-7. doi: 10.1309/PYQC-17CB-063T-Q07J.
4
[Non-urothelial tumors of the urinary tract].[泌尿道非尿路上皮肿瘤]
Verh Dtsch Ges Pathol. 1993;77:180-98.
5
Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.犬膀胱上皮肿瘤中尿路上皮蛋白III、细胞角蛋白7和细胞角蛋白20的免疫组织化学检测
Vet Pathol. 2003 Jan;40(1):55-62. doi: 10.1354/vp.40-1-55.
6
Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.具有脊索样特征的浸润性尿路上皮癌:12例以显著黏液样间质和索状上皮结构为特征的不同病例报告。
Am J Surg Pathol. 2009 Aug;33(8):1213-9. doi: 10.1097/PAS.0b013e3181a8ffbe.
7
Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.与天然尿路上皮组织相比,单层和体外分层的人尿路上皮细胞培养物中p63的免疫反应性。
Eur Urol. 2008 May;53(5):1066-72. doi: 10.1016/j.eururo.2007.10.026. Epub 2007 Oct 23.
8
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.胎盘S100(S100P)和GATA3:通过互补DNA微阵列发现的移行上皮和尿路上皮癌标志物。
Am J Surg Pathol. 2007 May;31(5):673-80. doi: 10.1097/01.pas.0000213438.01278.5f.
9
Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.尿路上皮蛋白III表达缺失与侵袭性膀胱癌的临床病理特征相关。
Urology. 2008 Aug;72(2):444-9. doi: 10.1016/j.urology.2007.11.128. Epub 2008 Mar 3.
10
Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.肾特异性钙黏蛋白在多种传统及新发现的肾上皮性肿瘤中的表达分析:诊断及组织发生学意义
Am J Surg Pathol. 2007 Oct;31(10):1528-33. doi: 10.1097/PAS.0b013e318058818c.

引用本文的文献

1
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.从癌症基因组图谱基因表达数据中挖掘谱系标记物以区分膀胱尿路上皮癌和前列腺腺癌。
Sci Rep. 2021 Mar 24;11(1):6765. doi: 10.1038/s41598-021-85993-x.
2
Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.利用 3D 膀胱癌类器官培养建立 2.5D 类器官培养模型。
Sci Rep. 2020 Jun 10;10(1):9393. doi: 10.1038/s41598-020-66229-w.
3
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
从TCGA数据库和膀胱癌患者的FFPE样本中检测到的GATA3的生物学和临床意义
Onco Targets Ther. 2020 Jan 31;13:945-958. doi: 10.2147/OTT.S237099. eCollection 2020.